Wuppertal, Germany

Leo Marx

USPTO Granted Patents = 4 

Average Co-Inventor Count = 10.2

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Martigny, CH (2023)
  • Wuppertal, DE (2021 - 2024)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
4 patents (USPTO):Explore Patents

I'm glad that you're interested in inventor Leo Marx from Wuppertal, DE, who holds 3 patents.

Latest Patents: Leo Marx's recent inventions include prodrugs of cytotoxic active agents with enzymatically cleavable groups. These cutting-edge prodrugs utilize a unique structural motif reduced to an asparagine derivative as a cleavage site for tumor-associated proteases such as legumain. This results in the release of cytotoxic drugs like kinesin spindle protein inhibitors targeted at hyperproliferative and angiogenic disorders, particularly cancers. The innovations aim at enhancing treatment and prevention methodologies for diseases.

Career Highlights: Leo Marx has made significant contributions at renowned companies such as Bayer Pharma Aktiengesellschaft and Bayer Aktiengesellschaft. His expertise and groundbreaking inventions have left a lasting impact on the pharmaceutical industry, particularly in the field of oncology.

Collaborations: Throughout his career, Leo Marx has collaborated closely with esteemed coworkers like Hans-Georg Lerchen and Anne-Sophie Rebstock. Their joint efforts have resulted in pioneering developments that have revolutionized the treatment landscape for various diseases.

In conclusion, Leo Marx's relentless pursuit of innovation and his remarkable contributions in developing prodrugs with enzymatically cleavable groups underscore his commitment to advancing healthcare solutions. His work continues to inspire professionals in the field and pave the way for future breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…